BOSTON & PARIS--(BUSINESS WIRE)--Organizers announced today that “French-American Innovation Days (FAID) 2016” will be held on Tuesday and Wednesday, February 9 and 10, 2016, at the MIT Media Lab, 75 Amherst Street, Cambridge, Mass. The FAID symposium’s organizers are: The Office for Science and Technology of the Embassy of France in the United-States in Boston; and, GLOBAL CARE Initiative (“GCI”).
Click here for registration, program, and other information.
The two-day event is focusing on the latest developments in Precision Medicine. It will bring together leading experts in the field, to explore how these developments impact clinical research. The Symposium is also expected to facilitate research and development partnerships among researchers, emerging and established companies, business development executives and investors in the United States and France.
“The FAID symposium will be the ideal venue at which life science investors, researchers and business development executives can learn and network and identify potential collaborators,” said Valéry Freland, Consul General of France in Boston.
“The FAID symposium will be of great interest to those in the life sciences in the U.S. and France who want to see science and technology transferred into clinical reality for the advancement of human health,” added Pascal Deschaseaux, MD, MBA, General Manager, CALYM, a GLOBAL CARE Initiative member.
Sponsorships opportunities are available, please contact GLOBAL CARE Initiative at contact@globalcare-initiative.com.
About FAID’s Organizers:
The
Office for Science and Technology of the Embassy of France in the
United-States
The Office for Science and Technology is a
team of professors, senior researchers and engineers, in Washington
D.C., in Boston, MA, and five other locations in the United States. Its
mission is to promote bilateral partnerships in science, technology and
innovation. It has been organizing the FAID conference in Boston since
2002. www.france-science.org
GLOBAL
CARE Initiative (Based in Paris and Lyon)
GCI is a
consortium of five Carnot Human Health Institutes that covers four
therapeutic fields in human health markets: Cancer, vision and audition
diseases and rehabilitation, infectious diseases and central nervous
system diseases. GCI brings together 2,500 researchers and a wide array
of technical assets and expertise and drives a budget of €31 million for
international business development and research.
